Procter & Gamble reported Q4 FY 2015 earnings of $1.04 per share (versus $1.06 in Q4 FY 2014), beating analysts' consensus of $0.98.

The company's quarterly revenues amounted to $16.915 bln (-8.5% y/y), generally in line with consensus estimate of $16.941 bln.

The company also issued downside guidance for FY 2016, projecting EPS of down 3-8% to $3.46-3.65 versus analysts' consensus of $3.75

PG rose to $78.00 (-+1.50%) in pre-market trading.